Hoan Van Tran, MD
Gastroenterology · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 32
- 9 carriers
- Office
- 1
Offices
1 location
Looking this up.
Hospitals listed: Enloe Health · Santa Clara Valley Medical Center. That is not proof they admit you there this week.
Plans that list them
32 plans · 9 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Tran’s office at (408) 538-8934 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
32 of 32 plans
| Alignment Health Advantage PPO (PPO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Prime (HMO-POS) | Anthem Blue Cross Partnership Plan | Listed | Oct 3, 2026 |
| Astiva Health C-SNP WOW - NorCal (HMO C-SNP) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Premier Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Savings Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Blue Shield Inspire (HMO) | Blue Shield of California | Listed | Aug 26, 2026 |
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Care Plan (HMO C-SNP) | Central Health Medicare Plan | Listed, may be out of date | Sep 15, 2025 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A108550 · Current
Licensed to practise in California · since 2009 · expires 2028-12-31 · St. George'S University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Enloe HealthChico, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Enloe Medical CenterPatients rate it 3 of 5 · 73% would definitely recommend itOverall rating: 3 of 5 starsWorse than the national rate — Rate of emergency department (ED) visits for patients receiving outpatient chemotherapy: 6.9 (5.5 to 8.6) · 730 cases, Jan 2024 – Dec 2024Better than the national rate — Clostridium Difficile (C.Diff): 0.185, Oct 2024 – Sep 2025
- Santa Clara Valley Medical CenterSan Jose, CAAcute Care Hospital · Government - Local · Has an emergency department · Birthing-friendlyPart of Santa Clara Valley Health and Hospital System, which runs 3 hospitalsPatients rate it 3 of 5 · 70% would definitely recommend itOverall rating: 2 of 5 starsWorse than the national rate — SSI - Colon Surgery: 2.572, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.563, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.256, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.369, Oct 2024 – Sep 2025
See every measure and the patient survey for Enloe Health
Behind the star rating — Deaths: 1 better, 7 the same, 0 worse of 8 measures. Safety: 4 better, 3 the same, 0 worse of 7 measures. Readmissions: 0 better, 9 the same, 2 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.9 (5.5 to 8.6) · 730 cases | Worse | Jan 2024 – Dec 2024 |
| Clostridium Difficile (C.Diff)Infections | 0.185 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.79 (0.96 to 2.62) · 2,849 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.99 (0.74 to 1.24) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 203.04 (164.55 to 241.54) · 191 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.8 · 117 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 9.8 · 377 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.4 · 377 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.2 · 1,088 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 16.2 · 1,160 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.2 · 375 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.1 · 4,102 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.22 (0.05 to 0.39) · 14,875 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.17 (0 to 0.34) · 15,303 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.75 (2.11 to 5.39) · 3,517 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2.14 (0.71 to 3.56) · 1,262 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.89 (1.62 to 4.17) · 3,062 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 6.91 (1.48 to 12.34) · 1,287 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.79 (1.66 to 7.91) · 1,219 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.04 (0.64 to 3.43) · 643 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.71 (0.24 to 1.18) · 11,884 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.3 · 150 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.739 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.481 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.381 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.344 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.1 · 328 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.7 · 1,020 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -4.9 · 400 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 9.3 · 1,292 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 13.3 · 1,204 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 1,055 cases | None | Jul 2023 – Jun 2025 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.4 (10.4 to 14.7) · 730 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.3 · 102 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.5 · 90 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.6 · 304 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 14.9 (12.1 to 18.1) · 3,626 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.8 to 1.2) · 1,340 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,476 patients answered, 21% of those asked)
| Cleanliness | 2 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 57% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 77% |
| Staff "always" explained | 59% |
| Yes, staff "did" give patients this information | 85% |
| Yes, staff "did" give patients information about help after discharge | 83% |
| Doctors "always" explained things so they could understand | 70% |
| Doctors "always" listened carefully | 75% |
| Doctors "always" treated them with courtesy and respect | 85% |
| Patients who gave a rating of "9" or "10" (high) | 69% |
| Staff "always" explained new medications | 74% |
| Nurses "always" explained things so they could understand | 73% |
| Nurses "always" listened carefully | 74% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 40% |
| "YES", patients would definitely recommend the hospital | 73% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 87% |
See every measure and the patient survey for Santa Clara Valley Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 1 worse of 8 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| SSI - Colon SurgeryInfections | 2.572 | Worse | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.563 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.256 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.369 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.25 (0.3 to 2.2) · 1,535 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.07 (0.76 to 1.38) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 214.59 (167.38 to 261.8) · 108 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.8 · 41 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6 · 141 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.2 · 124 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.3 · 501 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.9 · 653 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 348 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 4,502 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.24 (0.04 to 0.43) · 9,014 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.34 (0.15 to 0.52) · 9,216 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.54 (2.51 to 6.58) · 1,421 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.54 (0 to 3.2) · 288 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,446 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.61 (4.09 to 19.14) · 294 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.29 (3.39 to 11.2) · 299 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.9 (0.45 to 3.36) · 333 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.23 (0 to 0.78) · 7,538 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 5.4 · 94 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.735 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 2.573 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.6 · 185 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.1 · 951 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 56.3 · 128 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 6.4 · 644 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 1.3 · 699 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.3 · 921 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (3.9 to 8.1) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.6 (9.4 to 16.5) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 94 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.4 · 54 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 242 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.2 (9.9 to 17.4) · 702 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.4) · 195 cases | No different | Jan 2024 – Dec 2024 |
What patients said (4,032 patients answered, 29% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 2 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 70% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 82% |
| Yes, staff "did" give patients information about help after discharge | 82% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 67% |
| Staff "always" explained new medications | 71% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 69% |
| Nurses "always" treated them with courtesy and respect | 80% |
| "Always" quiet at night | 43% |
| "YES", patients would definitely recommend the hospital | 70% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 83% |
Original Medicare doctor bills
$42,252
Medicare paid this office $42,252 for 132 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 60 | $9,426 | $106 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 38 | $8,419 | $216 |
| New patient visit (45+ min) | 44 | $6,388 | $145 |
| Pathology examination of tissue using a microscope, intermediate complexity | 49 | $5,441 | $39 |
| Biopsy of large bowel using a flexible endoscope | 39 | $2,462 | $60 |
See all 8 services
| Return visit (30+ min) | 60 | $9,426 | $106 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 38 | $8,419 | $216 |
| New patient visit (45+ min) | 44 | $6,388 | $145 |
| Pathology examination of tissue using a microscope, intermediate complexity | 49 | $5,441 | $39 |
| Biopsy of large bowel using a flexible endoscope | 39 | $2,462 | $60 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 26 | $2,024 | $78 |
| New patient visit (30+ min) | 11 | $701 | $64 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 17 | $81 | $5 |
Procedures Medicare counted
| Colonoscopy | 166 | More than 90% of doctors who do this |
| Upper gastrointestinal (GI) endoscopy for acid reflux | 50 | More than 63% of doctors who do this |
Who their Medicare patients are
132 Original Medicare patients in 2024. Average age 73 · Women 49% · Also on Medicaid 79% · Health risk score 1.25. At or below the middle of the specialty; the typical gastroenterology clinician is at 1.42.
Conditions among them: High blood pressure 75% · Diabetes 44% · Coronary heart disease 20% · Chronic kidney disease 20% · Heart failure 13% · Cancer 11% · Atrial fibrillation 9% · COPD 8% · Depression 8%.
The office billed $239,273, Medicare allowed $57,214 and paid $42,252; for 450 services of 22 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 132 | 450 | 73 | 1.25 | $239,273 | $42,252 |
| 2023 | 199 | 793 | 73 | 1.18 | $252,665 | $65,177 |
| 2022 | 220 | 849 | 74 | 1.21 | $260,241 | $76,241 |
| 2021 | 665 | 1,359 | 72 | 1.46 | $409,249 | $116,175 |
| 2020 | 831 | 1,918 | 72 | 1.37 | $617,881 | $152,586 |
| 2019 | 899 | 2,134 | 71 | 1.47 | $687,345 | $177,227 |
| 2018 | 714 | 1,817 | 70 | 1.67 | $554,966 | $156,978 |
| 2017 | 778 | 1,936 | 71 | 1.62 | $597,430 | $169,869 |
| 2016 | 717 | 1,636 | 71 | 1.42 | $596,593 | $162,736 |
| 2015 | 459 | 932 | 71 | 1.51 | $390,254 | $108,407 |
| 2014 | 152 | 314 | 70 | 0.98 | $149,391 | $37,250 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 10 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 62 | $13,774 | $215 |
| Pathology examination of tissue using a microscope, intermediate complexity | 102 | $11,097 | $39 |
| New patient visit (45+ min) | 67 | $9,897 | $148 |
| Return visit (30+ min) | 56 | $8,662 | $117 |
| Biopsy of large bowel using a flexible endoscope | 81 | $5,150 | $61 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 38 | $2,880 | $76 |
| New patient visit (30+ min) | 21 | $2,191 | $104 |
| Special stained specimen slides to identify organisms including interpretation and report | 13 | $1,541 | $96 |
| New patient visit (15+ min) | 15 | $1,061 | $71 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 61 | $288 | $5 |
2022: 11 services
| New patient visit (45+ min) | 101 | $14,459 | $143 |
| Return visit (30+ min) | 60 | $12,119 | $122 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 51 | $11,416 | $224 |
| Pathology examination of tissue using a microscope, intermediate complexity | 90 | $10,136 | $38 |
| Biopsy of large bowel using a flexible endoscope | 63 | $5,210 | $83 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 39 | $3,609 | $90 |
| Special stained specimen slides to identify organisms including interpretation and report | 13 | $2,203 | $96 |
| New patient visit (30+ min) | 21 | $1,983 | $94 |
| Complete ultrasound scan of abdomen | 12 | $1,512 | $126 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 12 | $1,163 | $65 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 60 | $279 | $5 |
2021: 16 services
| Return visit (30+ min) | 307 | $23,397 | $67 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 84 | $17,581 | $209 |
| Biopsy of large bowel using a flexible endoscope | 168 | $16,770 | $99 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 159 | $10,985 | $66 |
| New patient visit (45+ min) | 37 | $5,854 | $158 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 55 | $5,718 | $100 |
| Pathology examination of tissue using a microscope, intermediate complexity | 34 | $3,315 | $37 |
| Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | 27 | $3,154 | $102 |
| Diagnostic exam of large bowel using a flexible endoscope | 21 | $2,905 | $138 |
| Control of bleeding of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 15 | $2,209 | $147 |
| Imaging of digestive tract done from the inside of the digestive tract | 19 | $2,010 | $106 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 20 | $1,627 | $81 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 15 | $1,002 | $63 |
| Injection of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 12 | $389 | $26 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 79 | $297 | $4 |
| Injection beneath lining of large bowel using a flexible endoscope | 17 | $290 | $17 |
2020: 17 services
| Return visit (30+ min) | 415 | $31,601 | $53 |
| Biopsy of large bowel using a flexible endoscope | 287 | $26,588 | $91 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 137 | $25,267 | $183 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 237 | $14,952 | $61 |
| Removal of external hemorrhoids by rubber banding | 11 | $5,940 | $152 |
| Control of bleeding of upper large bowel using a flexible endoscope | 29 | $5,925 | $204 |
| Diagnostic exam of large bowel using a flexible endoscope | 39 | $5,643 | $138 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 58 | $4,809 | $82 |
| Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | 40 | $4,403 | $98 |
| Control of bleeding of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 26 | $4,149 | $138 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 31 | $3,144 | $101 |
| Imaging of digestive tract done from the inside of the digestive tract | 24 | $2,587 | $99 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 13 | $1,995 | $153 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 25 | $1,625 | $56 |
| Injection of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 15 | $1,212 | $61 |
| Injection beneath lining of large bowel using a flexible endoscope | 41 | $629 | $15 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 111 | $369 | $3 |
2019: 19 services
| Return visit (30+ min) | 394 | $34,966 | $57 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 161 | $30,746 | $189 |
| Biopsy of large bowel using a flexible endoscope | 304 | $27,845 | $90 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 222 | $16,515 | $69 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 91 | $9,680 | $102 |
| Control of bleeding of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 30 | $5,442 | $147 |
| Tying of dilated veins of stomach and/or esophagus using a flexible endoscope | 18 | $5,336 | $191 |
| Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | 32 | $5,251 | $114 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 56 | $4,883 | $87 |
| Diagnostic exam of large bowel using a flexible endoscope | 29 | $4,266 | $147 |
| Control of bleeding of upper large bowel using a flexible endoscope | 18 | $3,858 | $214 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 63 | $3,807 | $55 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 20 | $3,715 | $186 |
| Imaging of digestive tract done from the inside of the digestive tract | 30 | $3,402 | $106 |
| New patient visit (45+ min) | 34 | $2,427 | $71 |
| Injection beneath lining of large bowel using a flexible endoscope | 63 | $842 | $13 |
| Return visit (30+ min) | 11 | $700 | $64 |
| Injection of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 14 | $646 | $27 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 133 | $529 | $4 |
2018: 25 services
| Return visit (30+ min) | 300 | $28,748 | $56 |
| Biopsy of large bowel using a flexible endoscope | 167 | $16,932 | $100 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 189 | $14,782 | $74 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 69 | $12,163 | $174 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 87 | $9,830 | $109 |
| New patient visit (45+ min) | 95 | $9,002 | $95 |
| Removal of large bowel tissue using a flexible endoscope | 25 | $7,187 | $276 |
| Tying of dilated veins of stomach and/or esophagus using a flexible endoscope | 16 | $5,098 | $189 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 31 | $5,081 | $164 |
| Diagnostic exam of large bowel using a flexible endoscope | 26 | $3,905 | $150 |
| Imaging of digestive tract done from the inside of the digestive tract | 31 | $3,617 | $106 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 53 | $3,485 | $58 |
| Control of bleeding of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 18 | $3,351 | $152 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 32 | $2,861 | $87 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 14 | $2,536 | $181 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 17 | $1,856 | $84 |
| Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | 16 | $1,680 | $105 |
| Biopsy of large bowel using a flexible endoscope | 15 | $1,499 | $100 |
| Long return visit (40+ min) | 12 | $1,131 | $81 |
| Injection of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 11 | $1,109 | $74 |
| Short return visit (20+ min) | 21 | $954 | $37 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 16 | $708 | $44 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 96 | $389 | $4 |
| Injection beneath lining of large bowel using a flexible endoscope | 13 | $177 | $14 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 14 | $62 | $4 |
2017: 21 services
| Return visit (30+ min) | 285 | $27,445 | $58 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 94 | $18,051 | $188 |
| Biopsy of large bowel using a flexible endoscope | 191 | $17,846 | $91 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 178 | $15,002 | $79 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 122 | $13,542 | $109 |
| New patient visit (45+ min) | 106 | $9,121 | $86 |
| Removal of large bowel tissue using a flexible endoscope | 26 | $8,024 | $277 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 35 | $6,541 | $187 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 83 | $6,292 | $58 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 34 | $5,581 | $164 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 30 | $3,723 | $85 |
| Imaging of digestive tract done from the inside of the digestive tract | 31 | $3,701 | $119 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 40 | $3,589 | $85 |
| Control of bleeding of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 19 | $3,385 | $154 |
| Diagnostic exam of large bowel using a flexible endoscope | 23 | $3,252 | $141 |
| Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | 20 | $2,785 | $121 |
| Study of esophagus to assess movement | 20 | $1,064 | $53 |
| Injection of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 12 | $691 | $49 |
| Short return visit (20+ min) | 15 | $621 | $37 |
| Prolonged monitoring and recording of esophageal function through nasal tube with electrode | 13 | $585 | $45 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 137 | $559 | $4 |
2016: 16 services
| Return visit (30+ min) | 194 | $20,483 | $58 |
| Biopsy of large bowel using a flexible endoscope | 186 | $17,342 | $91 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 89 | $15,556 | $167 |
| Removal of large bowel tissue using a flexible endoscope | 52 | $15,287 | $273 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 92 | $15,113 | $161 |
| New patient visit (45+ min) | 152 | $14,590 | $96 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 174 | $13,830 | $78 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 97 | $6,991 | $57 |
| Diagnostic exam of large bowel using a flexible endoscope | 37 | $5,363 | $145 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 28 | $5,295 | $189 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 46 | $4,992 | $109 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 33 | $3,093 | $94 |
| Imaging of digestive tract done from the inside of the digestive tract | 20 | $2,994 | $150 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 21 | $2,560 | $83 |
| Short return visit (20+ min) | 37 | $1,623 | $40 |
| Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | 11 | $1,351 | $104 |
2015: 18 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 44 | $11,015 | $250 |
| New patient visit (45+ min) | 100 | $10,519 | $105 |
| Biopsy of large bowel using a flexible endoscope | 62 | $9,911 | $157 |
| Imaging of digestive tract done from the inside of the digestive tract | 12 | $8,310 | $692 |
| Return visit (30+ min) | 55 | $6,997 | $78 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 79 | $6,038 | $76 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 35 | $5,704 | $158 |
| New patient visit (45+ min) | 52 | $5,278 | $102 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 20 | $4,175 | $209 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 44 | $3,959 | $57 |
| Return visit (30+ min) | 53 | $3,894 | $64 |
| New patient visit (60+ min) | 25 | $3,427 | $137 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 31 | $3,119 | $101 |
| Diagnostic exam of large bowel using a flexible endoscope | 16 | $2,326 | $145 |
| Short return visit (20+ min) | 36 | $2,119 | $50 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 14 | $2,050 | $82 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 13 | $1,256 | $97 |
| Short return visit (20+ min) | 15 | $621 | $41 |
2014: 8 services
| New patient visit (45+ min) | 61 | $7,863 | $129 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 22 | $5,824 | $253 |
| Biopsy of large bowel using a flexible endoscope | 28 | $4,183 | $149 |
| Return visit (30+ min) | 29 | $3,134 | $87 |
| Short return visit (20+ min) | 28 | $1,890 | $59 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 17 | $1,259 | $74 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 11 | $1,221 | $111 |
| New patient visit (30+ min) | 12 | $1,050 | $88 |
Medicaid work
$2,244 in 2024
Medicaid paid $2,244 for 622 billed services this clinician did in 2024, up to 24 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| COLONOSCOPY W/LESION REMOVAL | 48 | $1,077 |
| COLONOSCOPY AND BIOPSY | 84 | $658 |
| New patient visit (45+ min) | 84 | $219 |
| TISSUE EXAM BY PATHOLOGIST | 170 | $203 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate) | 73 | $87 |
| New patient visit (30+ min) | 86 | $0 |
| Return visit (30+ min) | 77 | $0 |
| 2024 | 622 | 7 | 24 | $2,244 |
| 2023 | 1,186 | 8 | 38 | $5,624 |
| 2022 | 1,003 | 7 | 25 | $5,077 |
| 2021 | 525 | 12 | 24 | $18,275 |
| 2020 | 824 | 10 | 25 | $48,200 |
| 2019 | 719 | 9 | 30 | $37,448 |
| 2018 | 462 | 5 | 31 | $33,978 |
See the largest Medicaid services in earlier years
2023
| COLONOSCOPY AND BIOPSY | 176 | $1,591 |
| Return visit (30+ min) | 125 | $1,338 |
| TISSUE EXAM BY PATHOLOGIST | 320 | $1,121 |
| New patient visit (45+ min) | 116 | $732 |
| New patient visit (30+ min) | 159 | $300 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate) | 246 | $244 |
| COLONOSCOPY W/LESION REMOVAL | 27 | $244 |
| Upper gastrointestinal endoscopy with biopsy | 17 | $54 |
2022
| COLONOSCOPY AND BIOPSY | 230 | $1,856 |
| TISSUE EXAM BY PATHOLOGIST | 301 | $1,112 |
| New patient visit (45+ min) | 91 | $859 |
| COLONOSCOPY W/LESION REMOVAL | 62 | $617 |
| Return visit (30+ min) | 70 | $307 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate) | 234 | $222 |
| Upper gastrointestinal endoscopy with biopsy | 15 | $104 |
2021
| Return visit (30+ min) | 131 | $9,172 |
| Upper gastrointestinal endoscopy with biopsy | 51 | $7,022 |
| COLONOSCOPY AND BIOPSY | 55 | $737 |
| IP/OBS CONSLTJ NEW/EST PT MOD MDM 60 MINUTES | 12 | $647 |
| Injection, propofol, 10 mg | 29 | $220 |
| New patient visit (45+ min) | 47 | $201 |
| Ringers lactate infusion, up to 1000 cc | 31 | $183 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate) | 53 | $92 |
| TISSUE EXAM BY PATHOLOGIST | 66 | $0 |
| OFFICE/OUTPATIENT NEW SF MDM 15 MINUTES | 17 | $0 |
| New patient visit (30+ min) | 21 | $0 |
| Hospital outpatient clinic visit for assessment and management of a patient | 12 | $0 |
2020
| Upper gastrointestinal endoscopy with biopsy | 152 | $15,114 |
| Return visit (30+ min) | 207 | $14,752 |
| COLONOSCOPY AND BIOPSY | 54 | $9,746 |
| Service | 28 | $4,420 |
| Injection, propofol, 10 mg | 159 | $949 |
| 1ST HOSPITAL IP/OBS CARE MODERATE MDM 55 MINUTES | 16 | $878 |
| Ringers lactate infusion, up to 1000 cc | 143 | $797 |
| Service | 28 | $790 |
| IP/OBS CONSLTJ NEW/EST PT MOD MDM 60 MINUTES | 12 | $754 |
| Hospital outpatient clinic visit for assessment and management of a patient | 25 | $0 |
2019
| Return visit (30+ min) | 223 | $13,300 |
| Upper gastrointestinal endoscopy with biopsy | 99 | $9,793 |
| COLONOSCOPY AND BIOPSY | 62 | $8,063 |
| Service | 26 | $4,052 |
| Injection, propofol, 10 mg | 109 | $769 |
| Service | 26 | $725 |
| Ringers lactate infusion, up to 1000 cc | 105 | $604 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate) | 12 | $143 |
| Hospital outpatient clinic visit for assessment and management of a patient | 57 | $0 |
2018
| Upper gastrointestinal endoscopy with biopsy | 112 | $15,067 |
| Return visit (30+ min) | 257 | $12,757 |
| COLONOSCOPY AND BIOPSY | 42 | $6,011 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate) | 12 | $143 |
| Hospital outpatient clinic visit for assessment and management of a patient | 39 | $0 |
Drugs they prescribed that Part D paid
$360,448
Pharmacies billed $360,448 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 1,165) in 2024. At or below the middle of the specialty; the typical gastroenterology clinician is at 0%.
977 generic and 188 brand-name prescriptions · $360,448 in drug cost · 32 antibiotic prescriptions to 17 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Vemlidy | 50 | $83,473 | $1,669 |
| Creon | 19 | $32,799 | $1,726 |
| Mesalamine | 13 | $18,352 | $1,412 |
| Linzess | 21 | $16,090 | $766 |
| Sod Sulf-Potass Sulf-Mag Sulf | 70 | $4,383 | $63 |
See all 20 drugs
| Vemlidy | 50 | $83,473 | $1,669 |
| Creon | 19 | $32,799 | $1,726 |
| Mesalamine | 13 | $18,352 | $1,412 |
| Linzess | 21 | $16,090 | $766 |
| Sod Sulf-Potass Sulf-Mag Sulf | 70 | $4,383 | $63 |
| Omeprazole | 361 | $3,862 | $11 |
| Ursodiol | 37 | $3,386 | $92 |
| Dicyclomine | 56 | $1,211 | $22 |
| Gavilyte-G | 79 | $1,191 | $15 |
| Pantoprazole | 79 | $934 | $12 |
| Peg-3350 and Electrolytes | 47 | $865 | $18 |
| Hydrocortisone | 49 | $776 | $16 |
| Procto-Med Hc | 28 | $643 | $23 |
| Sucralfate | 21 | $565 | $27 |
| Famotidine | 36 | $473 | $13 |
| Clarithromycin | 13 | $419 | $32 |
| Gavilyte-C | 17 | $359 | $21 |
| Amitriptyline | 48 | $143 | $3 |
| Amoxicillin | 11 | $95 | $9 |
| Furosemide | 14 | $11 | $1 |
Year by year
| 2024 | 1,165 | 369 | 0% (0) | 16% | $360,448 |
| 2023 | 1,151 | 414 | 0% (0) | 18% | $244,750 |
| 2022 | 1,302 | 475 | 0% (0) | 25% | $476,140 |
| 2021 | 2,747 | 621 | 0% (0) | None | $1,287,340 |
| 2020 | 3,102 | 616 | None | None | $1,340,482 |
| 2019 | 2,669 | 569 | 1% (17) | None | $664,990 |
| 2018 | 1,965 | 434 | 1% (13) | 17% | $686,688 |
| 2017 | 1,729 | 415 | 1% (13) | None | $886,171 |
| 2016 | 1,196 | 339 | None | 25% | $452,458 |
| 2015 | 631 | 210 | None | 17% | $251,273 |
| 2014 | 136 | 60 | None | None | $23,890 |
| 2013 | 21 | None | None | None | $281 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 21 drugs
| Vemlidy | 21 | $31,336 | $1,492 |
| Creon | 22 | $27,347 | $1,243 |
| Linzess | 23 | $13,542 | $589 |
| Sod Sulf-Potass Sulf-Mag Sulf | 111 | $8,506 | $77 |
| Omeprazole | 363 | $7,841 | $22 |
| Dicyclomine | 85 | $3,480 | $41 |
| Suprep | 30 | $3,347 | $112 |
| Pantoprazole | 79 | $2,277 | $29 |
| Ursodiol | 28 | $1,675 | $60 |
| Gavilyte-G | 74 | $1,493 | $20 |
| Hydrocortisone | 40 | $1,139 | $28 |
| Famotidine | 31 | $612 | $20 |
| Sucralfate | 21 | $562 | $27 |
| Proctozone-Hc | 23 | $537 | $23 |
| Clarithromycin | 14 | $436 | $31 |
| Peg-3350 and Electrolytes | 16 | $381 | $24 |
| Procto-Med Hc | 18 | $360 | $20 |
| Gavilyte-C | 15 | $294 | $20 |
| Peg 3350-Electrolyte | 12 | $289 | $24 |
| Amitriptyline | 21 | $183 | $9 |
| Amoxicillin | 14 | $181 | $13 |
2022: 24 drugs
| Xifaxan | 13 | $40,731 | $3,133 |
| Creon | 26 | $38,562 | $1,483 |
| Suprep | 155 | $17,633 | $114 |
| Linzess | 25 | $17,232 | $689 |
| Mesalamine | 18 | $16,757 | $931 |
| Omeprazole | 337 | $5,336 | $16 |
| Ursodiol | 18 | $2,941 | $163 |
| Dicyclomine | 70 | $2,592 | $37 |
| Pantoprazole | 105 | $2,147 | $20 |
| Hydrocortisone | 53 | $1,870 | $35 |
| Sod Sulf-Potass Sulf-Mag Sulf | 23 | $1,794 | $78 |
| Proctozone-Hc | 32 | $1,429 | $45 |
| Famotidine | 76 | $850 | $11 |
| Sucralfate | 13 | $794 | $61 |
| Clarithromycin | 12 | $561 | $47 |
| Peg-3350 and Electrolytes | 35 | $543 | $16 |
| Proctosol-Hc | 18 | $445 | $25 |
| Gavilyte-C | 23 | $407 | $18 |
| Gavilyte-G | 24 | $358 | $15 |
| Propranolol | 14 | $267 | $19 |
| Amitriptyline | 28 | $242 | $9 |
| Peg 3350-Electrolyte | 11 | $233 | $21 |
| Amoxicillin | 11 | $125 | $11 |
| Metronidazole | 11 | $112 | $10 |
2021: 41 drugs
| Stelara | 22 | $554,858 | $25,221 |
| Humira | 20 | $165,599 | $8,280 |
| Creon | 60 | $78,533 | $1,309 |
| Xifaxan | 28 | $71,660 | $2,559 |
| Mesalamine | 78 | $65,321 | $837 |
| Linzess | 87 | $53,010 | $609 |
| Viberzi | 12 | $17,535 | $1,461 |
| Omeprazole | 605 | $10,566 | $17 |
| Dexilant | 19 | $8,773 | $462 |
| Movantik | 18 | $8,437 | $469 |
| Suprep | 70 | $7,688 | $110 |
| Dicyclomine | 223 | $6,754 | $30 |
| Amitiza | 16 | $6,280 | $393 |
| Budesonide Ec | 15 | $6,060 | $404 |
| Lactulose | 28 | $4,930 | $176 |
| Cholestyramine | 31 | $4,661 | $150 |
| Sucralfate | 59 | $4,329 | $73 |
| Pantoprazole | 200 | $3,910 | $20 |
| Famotidine | 170 | $2,978 | $18 |
| Entecavir | 25 | $2,655 | $106 |
| Colestipol | 17 | $2,602 | $153 |
| Peg 3350-Electrolyte | 107 | $1,787 | $17 |
| Azathioprine | 19 | $1,607 | $85 |
| Ondansetron Odt | 129 | $1,584 | $12 |
| Esomeprazole Magnesium | 14 | $1,045 | $75 |
| Propranolol | 66 | $951 | $14 |
| Rabeprazole | 12 | $827 | $69 |
| Constulose | 11 | $738 | $67 |
| Amitriptyline | 81 | $708 | $9 |
| Peg-3350 and Electrolytes | 40 | $524 | $13 |
| Gavilyte-C | 33 | $511 | $15 |
| Spironolactone | 26 | $395 | $15 |
| Proctosol-Hc | 19 | $313 | $16 |
| Metoclopramide | 41 | $286 | $7 |
| Nortriptyline | 18 | $270 | $15 |
| Gavilyte-G | 20 | $239 | $12 |
| Buspirone | 14 | $203 | $14 |
| Prochlorperazine Maleate | 16 | $119 | $7 |
| Ciprofloxacin | 16 | $115 | $7 |
| Furosemide | 20 | $82 | $4 |
| Metronidazole | 12 | $73 | $6 |
2020: 44 drugs
| Humira | 12 | $258,672 | $21,556 |
| Stelara | 11 | $225,785 | $20,526 |
| Humira | 26 | $212,856 | $8,187 |
| Creon | 89 | $103,028 | $1,158 |
| Mesalamine | 83 | $52,202 | $629 |
| Linzess | 76 | $43,848 | $577 |
| Amitiza | 74 | $28,664 | $387 |
| Xifaxan | 11 | $22,161 | $2,015 |
| Dicyclomine | 286 | $10,546 | $37 |
| Omeprazole | 695 | $10,187 | $15 |
| Budesonide Ec | 27 | $9,658 | $358 |
| Entecavir | 20 | $8,010 | $401 |
| Cholestyramine | 36 | $7,769 | $216 |
| Sucralfate | 67 | $5,969 | $89 |
| Movantik | 13 | $4,755 | $366 |
| Balsalazide Disodium | 14 | $4,152 | $297 |
| Pantoprazole | 246 | $4,088 | $17 |
| Esomeprazole Magnesium | 13 | $2,893 | $223 |
| Peg 3350-Electrolyte | 135 | $1,988 | $15 |
| Famotidine | 146 | $1,901 | $13 |
| Ondansetron Odt | 232 | $1,794 | $8 |
| Azathioprine | 16 | $1,379 | $86 |
| Colestipol | 13 | $1,327 | $102 |
| Prevalite | 11 | $1,280 | $116 |
| Rabeprazole | 18 | $1,091 | $61 |
| Lactulose | 30 | $944 | $31 |
| Metoclopramide | 75 | $866 | $12 |
| Lansoprazole | 15 | $712 | $47 |
| Propranolol | 43 | $692 | $16 |
| Gavilyte-G | 53 | $656 | $12 |
| Cimetidine | 13 | $648 | $50 |
| Gavilyte-N | 43 | $616 | $14 |
| Amitriptyline | 36 | $483 | $13 |
| Gavilyte-C | 36 | $459 | $13 |
| Loperamide | 12 | $345 | $29 |
| Prochlorperazine Maleate | 12 | $341 | $28 |
| Prednisone | 13 | $301 | $23 |
| Spironolactone | 18 | $246 | $14 |
| Peg-3350 and Electrolytes | 20 | $226 | $11 |
| Ciprofloxacin | 25 | $153 | $6 |
| Metronidazole | 19 | $148 | $8 |
| Mirtazapine | 11 | $121 | $11 |
| Nortriptyline | 16 | $109 | $7 |
| Furosemide | 22 | $84 | $4 |
2019: 39 drugs
| Humira | 36 | $254,185 | $7,061 |
| Mesalamine | 90 | $47,978 | $533 |
| Asacol Hd | 17 | $29,097 | $1,712 |
| Linzess | 57 | $28,885 | $507 |
| Amitiza | 75 | $28,482 | $380 |
| Creon | 25 | $23,148 | $926 |
| Omeprazole | 619 | $10,488 | $17 |
| Budesonide Ec | 26 | $8,915 | $343 |
| Esomeprazole Magnesium | 27 | $5,615 | $208 |
| Pantoprazole | 277 | $5,230 | $19 |
| Movantik | 14 | $5,026 | $359 |
| Dicyclomine | 178 | $4,638 | $26 |
| Cholestyramine | 22 | $3,790 | $172 |
| Entecavir | 13 | $2,744 | $211 |
| Sucralfate | 60 | $2,450 | $41 |
| Peg 3350-Electrolyte | 124 | $2,165 | $17 |
| Azathioprine | 17 | $1,825 | $107 |
| Rabeprazole | 24 | $1,756 | $73 |
| Ranitidine | 89 | $1,011 | $11 |
| Ondansetron Odt | 187 | $999 | $5 |
| Lansoprazole | 18 | $694 | $39 |
| Diphenoxylate-Atropine | 11 | $670 | $61 |
| Propranolol | 42 | $643 | $15 |
| Metoclopramide | 48 | $641 | $13 |
| Gavilyte-N | 40 | $565 | $14 |
| Gavilyte-G | 45 | $544 | $12 |
| Gavilyte-C | 37 | $463 | $13 |
| Amitriptyline | 29 | $406 | $14 |
| Prednisone | 13 | $377 | $29 |
| Spironolactone | 23 | $285 | $12 |
| Prochlorperazine Maleate | 21 | $255 | $12 |
| Peg 3350-Electrolyte | 27 | $253 | $9 |
| Famotidine | 25 | $237 | $9 |
| Metronidazole | 15 | $189 | $13 |
| Tramadol | 17 | $132 | $8 |
| Ciprofloxacin | 15 | $129 | $9 |
| Duloxetine | 12 | $105 | $9 |
| Nortriptyline | 13 | $77 | $6 |
| Furosemide | 14 | $51 | $4 |
2018: 35 drugs
| Humira | 14 | $82,490 | $5,892 |
| Linzess | 65 | $33,633 | $517 |
| Mesalamine | 32 | $28,471 | $890 |
| Xifaxan | 14 | $24,921 | $1,780 |
| Amitiza | 42 | $16,392 | $390 |
| Entecavir | 13 | $10,861 | $835 |
| Budesonide Ec | 21 | $7,490 | $357 |
| Ursodiol | 15 | $5,931 | $395 |
| Omeprazole | 460 | $5,902 | $13 |
| Movantik | 13 | $4,525 | $348 |
| Cholestyramine | 21 | $2,753 | $131 |
| Pantoprazole | 228 | $2,745 | $12 |
| Esomeprazole Magnesium | 18 | $2,013 | $112 |
| Polyethylene Glycol 3350 | 94 | $1,840 | $20 |
| Dicyclomine | 121 | $1,489 | $12 |
| Peg 3350-Electrolyte | 86 | $1,375 | $16 |
| Azathioprine | 17 | $1,312 | $77 |
| Sucralfate | 35 | $1,203 | $34 |
| Ranitidine | 84 | $814 | $10 |
| Propranolol | 64 | $766 | $12 |
| Spironolactone | 44 | $560 | $13 |
| Gavilyte-N | 33 | $549 | $17 |
| Rabeprazole | 11 | $475 | $43 |
| Peg 3350-Electrolyte | 40 | $443 | $11 |
| Ondansetron Odt | 16 | $369 | $23 |
| Metoclopramide | 30 | $318 | $11 |
| Gavilyte-G | 20 | $261 | $13 |
| Nortriptyline | 36 | $226 | $6 |
| Buspirone | 21 | $222 | $11 |
| Ciprofloxacin | 18 | $221 | $12 |
| Baclofen | 11 | $203 | $18 |
| Gavilyte-C | 15 | $196 | $13 |
| Furosemide | 40 | $156 | $4 |
| Metronidazole | 11 | $127 | $12 |
| Tramadol | 12 | $90 | $7 |
2017: 32 drugs
| Harvoni | 16 | $520,904 | $32,556 |
| Humira | 17 | $76,578 | $4,505 |
| Mesalamine | 16 | $25,140 | $1,571 |
| Lialda | 22 | $19,570 | $890 |
| Dexilant | 22 | $17,242 | $784 |
| Budesonide Ec | 15 | $12,506 | $834 |
| Linzess | 29 | $11,066 | $382 |
| Amitiza | 26 | $10,186 | $392 |
| Omeprazole | 405 | $5,946 | $15 |
| Movantik | 11 | $3,456 | $314 |
| Esomeprazole Magnesium | 31 | $2,989 | $96 |
| Polyethylene Glycol 3350 | 103 | $2,168 | $21 |
| Cholestyramine | 15 | $2,000 | $133 |
| Pantoprazole | 130 | $1,602 | $12 |
| Peg 3350-Electrolyte | 97 | $1,408 | $15 |
| Sucralfate | 32 | $1,229 | $38 |
| Dicyclomine | 99 | $951 | $10 |
| Propranolol | 86 | $921 | $11 |
| Gavilyte-N | 45 | $775 | $17 |
| Ranitidine | 76 | $764 | $10 |
| Azathioprine | 11 | $411 | $37 |
| Famotidine | 15 | $369 | $25 |
| Peg 3350-Electrolyte | 28 | $330 | $12 |
| Lansoprazole | 11 | $330 | $30 |
| Ciprofloxacin | 19 | $300 | $16 |
| Gavilyte-G | 17 | $236 | $14 |
| Peg-3350 and Electrolytes | 16 | $183 | $11 |
| Metoclopramide | 33 | $180 | $5 |
| Spironolactone | 19 | $152 | $8 |
| Nortriptyline | 17 | $104 | $6 |
| Tramadol | 13 | $97 | $7 |
| Furosemide | 33 | $72 | $2 |
2016: 26 drugs
| Creon | 13 | $24,879 | $1,914 |
| Lialda | 14 | $16,407 | $1,172 |
| Budesonide Ec | 18 | $14,676 | $815 |
| Amitiza | 31 | $11,552 | $373 |
| Dexilant | 23 | $11,399 | $496 |
| Esomeprazole Magnesium | 28 | $6,563 | $234 |
| Linzess | 13 | $4,861 | $374 |
| Cholestyramine | 27 | $2,969 | $110 |
| Omeprazole | 210 | $2,644 | $13 |
| Polyethylene Glycol 3350 | 75 | $1,573 | $21 |
| Peg 3350-Electrolyte | 67 | $1,051 | $16 |
| Gavilyte-N | 46 | $849 | $18 |
| Dicyclomine | 76 | $766 | $10 |
| Pantoprazole | 58 | $707 | $12 |
| Sucralfate | 15 | $561 | $37 |
| Ranitidine | 66 | $508 | $8 |
| Gavilyte-G | 26 | $352 | $14 |
| Spironolactone | 26 | $270 | $10 |
| Peg 3350-Electrolyte | 25 | $258 | $10 |
| Propranolol | 17 | $208 | $12 |
| Ciprofloxacin | 16 | $198 | $12 |
| Trilyte With Flavor Packets | 12 | $195 | $16 |
| Peg-3350 and Electrolytes | 11 | $150 | $14 |
| Metoclopramide | 19 | $128 | $7 |
| Furosemide | 22 | $89 | $4 |
| Nortriptyline | 12 | $85 | $7 |
2015: 12 drugs
| Nexium | 15 | $7,521 | $501 |
| Cholestyramine | 26 | $3,346 | $129 |
| Omeprazole | 150 | $2,282 | $15 |
| Polyethylene Glycol 3350 | 75 | $1,689 | $23 |
| Moviprep | 12 | $982 | $82 |
| Peg 3350-Electrolyte | 18 | $308 | $17 |
| Pantoprazole | 25 | $275 | $11 |
| Gavilyte-N | 14 | $267 | $19 |
| Ranitidine | 29 | $253 | $9 |
| Dicyclomine | 19 | $148 | $8 |
| Gavilyte-G | 11 | $148 | $13 |
| Metoclopramide | 17 | $100 | $6 |
2014: 2 drugs
| Polyethylene Glycol 3350 | 27 | $499 | $18 |
| Omeprazole | 16 | $291 | $18 |
Money from drug and device companies
$454 in 2025
| 2025 | 6 | 21 | None | $454 |
| 2024 | 3 | 7 | None | $146 |
| 2023 | 3 | 15 | None | $896 |
| 2022 | 3 | 5 | None | $227 |
| 2021 | 3 | 8 | None | $276 |
| 2020 | 1 | 1 | None | $17 |
| 2019 | 2 | 4 | None | $97 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Abbvie | Linzess | $163 | 9 payments
|
| Aimmune Therapeutics | Zenpep | $113 | 4 payments
|
| Gilead Sciences | None | $76 | 3 payments
|
| Phathom Pharmaceuticals | Voquezna | $51 | 2 payments
|
| Pfizer | Velsipity | $36 | 2 payments
|
| Braintree Laboratories | Sutab | $14 | 1 payment
|
See all 21 published payments
| Pfizer | Meals · 2025-12-04 | Velsipity | $20 |
| Aimmune Therapeutics | Meals · 2025-11-19 | Zenpep | $30 |
| Phathom Pharmaceuticals | Meals · 2025-10-29 | Voquezna | $31 |
| Gilead Sciences | Meals · 2025-10-08 | None | $28 |
| Abbvie | Meals · 2025-09-04 | Linzess | $33 |
| Abbvie | Meals · 2025-07-24 | Linzess | $15 |
| Aimmune Therapeutics | Meals · 2025-07-24 | Zenpep | $30 |
| Abbvie | Meals · 2025-07-11 | Linzess | $24 |
| Aimmune Therapeutics | Meals · 2025-07-03 | Zenpep | $28 |
| Gilead Sciences | Meals · 2025-06-19 | None | $22 |
| Abbvie | Meals · 2025-06-18 | Linzess | $23 |
| Pfizer | Meals · 2025-06-12 | Xeljanz | $16 |
| Braintree Laboratories | Meals · 2025-06-11 | Sutab | $14 |
| Phathom Pharmaceuticals | Meals · 2025-05-30 | Voquezna | $21 |
| Aimmune Therapeutics | Meals · 2025-05-27 | Zenpep | $26 |
| Abbvie | Meals · 2025-05-22 | Linzess | $24 |
| Abbvie | Meals · 2025-03-15 | Linzess | $6 |
| Abbvie | Meals · 2025-03-04 | Linzess | $20 |
| Abbvie | Meals · 2025-02-28 | Linzess | $2 |
| Abbvie | Meals · 2025-02-18 | Linzess | $16 |
| Gilead Sciences | Meals · 2025-02-05 | None | $27 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $146
| Abbvie | Mavyret | $101 | 5 payments
|
| Salix Pharmaceuticals a division of Bausch Health US | Xifaxan | $24 | 1 payment
|
| Gilead Sciences | None | $21 | 1 payment
|
2023: $896
| Orthofix Medical | None | $625 | 2 payments
|
| Gilead Sciences | Vemlidy | $157 | 7 payments
|
| AbbVie | Mavyret | $113 | 6 payments
|
2022: $227
| Orthofix Medical | M6-C | $131 | 1 payment
|
| Abbvie | Mavyret | $69 | 3 payments
|
| Gilead Sciences | None | $27 | 1 payment
|
2021: $276
| Gilead Sciences | Epclusa | $236 | 6 payments
|
| Takeda Pharmaceuticals U.S.A. | Entyvio | $25 | 1 payment
|
| AbbVie | Humira | $16 | 1 payment
|
2020: $17
| Boston Scientific | Orca | $17 | 1 payment
|
2019: $97
| Stryker | General K2m Product Discussion | $74 | 2 payments
|
| Boston Scientific | General Biopsy | $23 | 2 payments
|
Research money
Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.
| E.R. Squibb & Sons, L.L.C. · A Phase 4, Global, Prospective, Open Label Study of Ozanimod To Explore the Safety, Efficacy, Quality of Life, and Biomarker Response in Participants With Moderate To Severe Ulcerative Colitis in Clinical Practice · 2024 | Their institution | $21,802 |
| E.R. Squibb & Sons, L.L.C. · An Open-Label Study of Ozanimod in Moderate To Severe Ulcerative Colitis in Clinical Practice · 2025 | Their institution | $15,245 |
| E.R. Squibb & Sons, L.L.C. · A Phase 4, Global, Prospective, Open Label Study of Ozanimod To Explore the Safety, Efficacy, Quality of Life, and Biomarker Response in Participants With Moderate To Severe Ulcerative Colitis in Clinical Practice · 2023 | Their institution | $12,500 |
| E.R. Squibb & Sons, L.L.C. · An Open-Label Study of Ozanimod in Moderate To Severe Ulcerative Colitis in Clinical Practice · 2024 | Their institution | $2,626 |
| E.R. Squibb & Sons, L.L.C. · UC Community Study · 2023 | Their institution | $2,056 |
Professional record
- NPI
- 1982876785
- Licence
- CA A108550, CA A108850California A108550: Current · expires 2028-12-31
- Trained
- University of California, Davis School of Medicine, 2008
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- Yes
- Taxonomy
- Federal specialty code 207RG0100X (207RG0100X); Internal medicine (207R00000X)
- Mailing address
- 200 Jose Figueres Ave Ste 355, San Jose, CA, 95116
- NPI first listed
- 2008-04-01
- NPI last updated
- 2025-06-10
- NPI record certified
- 2025-06-10
This is when the NPI record was last certified, not a medical board exam.